Almost 180 thousand shares traded, while the 3-month daily average volume is just above 30 thousand.
Beijing Med-Pharm is an end-to-end pharmaceutical distributor headquartered in the U.S., but caters to Western drug companies who intend on marketing to China.
Some of the company's services include pre-market analysis, clinical trial management, market research, and pharmaceutical distribution to physicians and other healthcare providers.
The company holds almost $4 million in cash, but carries a small debt of only $800 thousand as last reported on Yahoo! Finance.
Shares of the company's tock ended trading on Wednesday at $5.55 a share, and made a new intraday high of $6.10.
Beijing Med-Pharm has made BHI's Watch List.
BJGP 1-yr chart: